Le Lézard
Classified in: Health
Subjects: MAV, CFG

/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Thursday, March 7, 2024/


OTTAWA, ON, March 6, 2024 /CNW/ -

Note: All times local

Greater Toronto Area, Ontario



11:15 a.m.

The Prime Minister will meet with nurses and physicians.




Note for media:

  • Pooled photo opportunity


11:30 a.m.

The Prime Minister will make a pharmacare announcement. The Deputy Prime Minister
and Minister of Finance, Chrystia Freeland, and the Minister for Women and Gender
Equality and Youth, Marci Ien, will also be in attendance. A media availability will follow.




Notes for media: 

  • Open coverage
  • Media are asked to arrive no later than 10:30 a.m.
  • Media interested in participating can contact [email protected] for details.


3:30 p.m.

The Prime Minister will meet with health care professionals and non-profit diabetes
advocates.




Note for media:

  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 09:29
Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has completed the 0.09 mg/kg dose group of the Phase 1...

at 09:27
Natrol® Brand Unveils New Sleep Spiral Survey Discovering Root Causes of Sleep Challenges for Women
According to findings from Natrol®, the nation's leading sleep aid brand^, and its new Sleep Spiral Survey*, 45% of women ages 40 - 60 say they are losing more than two hours of sleep a night due to spiraling thought while 10% of women report they...

at 09:25
Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform
Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing more effective drugs to treat age-related...

at 09:25
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Sapio Sciences, the science-awaretm lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information...

at 09:25
Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Lantern Pharma Inc. , an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today announced that the FDA has granted Fast Track...

at 09:20
CuraSen Therapeutics Appoints Kathleen Sereda Glaub Chief Executive Officer
CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral, rapid onset, small molecule drugs to treat psychiatric and neurodegenerative diseases, announced today that it has appointed Kathleen Sereda Glaub, MBA, formerly...

More news about Health...


News published on and distributed by: